4LSC2554 Dactolisib – 915019-65-7

Catalog Number: 4LSC2554

CAS #: 915019-65-7

Name: Dactolisib, NVP-BEZ235, 2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)propanenitrile

Molecular Formula: C₃₀H₂₃N₅O

Molecular Weight: 469.55 g/mol

Specification:

Minimum purity: 95.0 %

Product Description:

Dactolisib is a phosphatidylinositol 3 kinase (PI3K) inhibitor and mammalian target of rapamycin (mTOR) inhibitor developed for treatment of bladder, breast and renal cell carcinoma, prostate cancer.